FDA Proposes Ban on a ‘Useless’ Decongestant, Phenylephrine
THURSDAY, Nov. 7, 2024 (HealthDay News) — More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal con
Related Articles
Stimulant Use Is Contributing to Rising Fatal Drug Overdoses
Stimulant use is on the rise across the United States. In 2022, more than 10.2 million people aged 12 and older misused stimulants—a class of…
Ultrathin polymer membrane for improved hole extraction and ion blocking in perovskite solar cells
Nature Communications – The operational lifetimes of n-i-p perovskite solar cells have been limited by the layer-to layer ion diffusion in the perovskite/hole-transport layer heterojunction.…
FDA Wraps Up 2024 Handing Out Several Notable Regulatory Decisions – MedCity News
Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.
Questions for RFK Jr.’s Senate Confirmation: Part I
RFK Jr. will soon be asked questions about heading the Department of Health and Human Services. Here are some suggestions.
Move less, spend more: the metabolic demands of short walking bouts | Proceedings of the Royal Society B: Biological Sciences
The metabolic cost of steady-state walking is well known; however, across legged animals, most walking bouts are too short to reach steady state. Here, we…
Best of 2024: Mixed Long-term Effects of Calcium and Vitamin D in Postmenopausal Women | RheumNow
A follow-up analysis of a randomized clinical trial found that the use of calcium and vitamin D supplements among postmenopausal women was associated with decreased…
Seeking Solutions to Burnout Among Emergency Physicians
While the culture is changing slowly, today’s residents and early-career emergency physicians are feeling the stress just as much as previous generations.
Eggs, pizza, Lay’s and more: the mounting list of FDA recalls
The FDA recently gave some Costco eggs their highest recall classification.
Four digital health unicorns on what they expect in 2025
Top executives at Omada, Transcarent, Hinge Health and Maven Clinic reflect on the year that passed, and the year ahead for their companies.
Planet-friendly school meals: opportunities to improve children’s health and leverage change in food systems
Food systems are facing a global crisis. Most countries are falling behind rather than progressing toward achieving the seven global nutrition targets set for 2030,1…
